Key facts
- Parasight System’s last known valuation is $60.0M (Feb 2026).
- It has raised $17.1M across 1 recorded rounds; the latest was Seed Round ($895K) in Oct 2025.
- Notable investors include Keyhorse Capital, United States Department of Agriculture, Bluegrass Angels, Global Equity Ventures, Strike Ventures — 6 tracked in total.
- Parasight System has filed 2 Form Ds with the SEC since 2024, most recently Nov 2025 ($895K sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Parasight System
Funding rounds
1 roundsAbout Parasight System
Developer of a veterinary diagnostic platform designed to support comprehensive in-clinic identification of parasites, pathogens, and hematologic indicators across diverse sample types. The company offers an all-in-one analyzer that integrates AI-driven fluorescence technologies for fecal, blood, and mucosal evaluations along with digital imaging and automated counts, enabling veterinary clinics, livestock operations, and mixed-animal practices to perform broad diagnostic panels with consistent accuracy, shorter turnaround times, and improved workflow efficiency.
- Sector
- Healthcare
- HQ
- Lexington, KY, United States
- Founded
- 2014
- Employees
- 18
- Website
- parasightsystem.com/
- Ownership
- Privately Held (backing)
Parasight System doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Parasight System shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Parasight System in its N-PORT filings yet. We sweep new filings monthly.